of adenylate cyclase (Enjalbert & Bockaert, 1983) , or inhibition of inositol phospholipid metabolism (Simmonds & Strange, 1985) . In order to understand fully the mechanism of action of the D,-receptor, it will be necessary to isolate and characterize the various components of the D,-receptor system and reconstitute them in a defined environment.
A monoclonal antibody directed against the D2-receptor would be of great value for studies on the receptor, particularly in purification and cellular localization of receptors. Immunisation of mice with caudate nucleus membranes, solubilized D, -receptor preparation and D, -receptor partially purified on wheatgerm agglutinin-agarose and the subsequent use of hybridoma technology has been employed in an attempt to raise a monoclonal antibody directed against the D2-receptor (Strange et al., 1986) . In no case was such an antibody obtained. Another approach, which avoids the problems inherent in isolation and purification of the receptor, is through the production of antiidiotypic antibodies. In this approach, antibodies are raised against a D,-receptor-specific drug. Antibodies (anti-idiotypes) raised against the first antibody may be anti-receptor antibodies (for a review, see Farid & Lo, 1985) . In the present report we have attempted to use this strategy with monoclonal antibodies using the D,-receptor-selective drug (Juszczak & Strange, 1985) . Haloperidol was derivatized either via the carbonyl group using carboxymethoxylamine (type I haloperidol) or via the hydroxyl group using succinyl dichloride (type I1 haloperidol). Both derivatives were coupled to albumin and used to immunize mice. Hybridoma technology was applied and seven hybridomas secreting monoclonal antibodies (designated type 1 or type I1 according to the derivative used) specific for haloperidol have been obtained; the properties of some of the monoclonal antibodies are given in Table I . Both type I and type I1 monoclonal antibodies bind ['Hlhaloperidol with high affinity but differ in their selectivity for binding of other substances, as judged by the ability of these substances to displace [' Hlhaloperidol binding. Type I monoclonal antibodies seem to be specific for haloperidol, whereas type I1 monoclonal antibodies can bind a range of substances, with a substantial affinity for the butyrophenones, droperidol, haloperidol and spiperone, and a weak but significant affinity for apomorphine, (+)-butaclamol and dopamine.
Immunization of rabbits with purified type 1 monoclonal antibody, gave antisera which at dilutions between 1/10000 and 1/15 000 inhibited 50% of ['H]haloperidol binding to type 1 monoclonal antibody. However, these rabbit sera did not affect [" Hlspiperone binding to caudate nucleus membranes and thus were not anti-D,-receptor antibodies.
In conclusion, monoclonal antibodies have been raised against haloperidol. These antibodies, in addition to binding haloperidol with high affinity, also bind other D,-receptor-selective ligands with high affinity. Anti-idiotypic antibodies have been obtained directed against the antihaloperidol antibodies, but these were not anti-D,-receptor antibodies.
We thank the Wellcome Trust for financial support. D,-dopamine receptors exist at high densities in the anterior pituitary and in the brain, particularly in the striatum. In the anterior pituitary, D,-receptors mediate the inhibition of prolactin release via the inhibition of adenylate cyclase (Caron et al., 1978; Enjalbert & Bockaert, 1983) , whereas in the brain they are involved in motor function and control of *Present address: The Biological Laboratory, The University, Canterbury, Kent CT2 7NJ. U.K.
behaviour. The D,,-receptor has also been shown to inhibit polyphosphoinositide metabolism (Simmonds & Strange, 1985) . In order to fully elucidate its transduction mechanism pure receptor must be reconstituted into model systems. As a first step towards this aim we report here initial results on receptor purification using affinity chromatography.
The carboxymethoxyl oxime derivative of haloperidol was prepared (Juszczak & Strange, 1985) and immobilized on w-aminodecyl-Sepharose (S. Worrall, R. A. Williamson & P. G. Strange, unpublished work). A mixed mitochondrialmicrosomal membrane preparation of bovine caudate nucleues was prepared as described by Withy el al. (1982) . The D,-receptors contained in the membranes were solubilized using the method of Hall el al. (1983) with the I986 619th MEETING. CAMBRIDGE 1 I39 modification that for solubilization they were resuspended at 4 mg of protein/ml in 20 mM-Hepes buffer pH 7.4 (containing 0.3% cholate, 1 M-NaCI, IOmM-EDTA, 1 mM-EGTA).
The solubilized preparation obtained after centrifugation was diluted 3 : 1 with 20 mM-Hepes buffer pH 7.4 (containing IOmM-EDTA and 1 mM-EGTA) and incubated with the affinity matrix for 15-20 h at 4°C. The gel was then washed with 20-50 bed vol. of 20 mM-Hepes (containing 0.2% cholate, 700 mM-NaC1, 10 mM-EDTA, 2 mM-sodium acetate and 0.04% phosphatidylcholine) over a 2 h period. Bound receptor was eluted over 48 h with 1 bed vol. of 1 mMmetoclopramide in wash buffer. This eluate was subjected to further purification on a wheatgerm lectin-Sepharose column as described by Abbott & Strange (1985) . Protein concentrations were generally determined using the method of Lowry et al. (1951) as modified by Wheatly & Strange (1983) . except for the wheatgerm lectin column eluates which were assayed using the Amidoschwarz procedure of Schaffner & Weissmann ( 1973) . Receptor-binding activity was assayed using ['Hlspiperone as described in Hall et al. (1983) .
In a series of experiments 73% of the applied binding activity (8696 f 631 fmol, mean f s.E.M., n = 7) was retained on the affinity column, the remainder being recovered in the run through and wash fractions. In contrast, ofthe applied protein (85.9 k 3.7 mg, mean k s.E.M.) more than 98% was recovered in these fractions. Only 2% of the protein eluted from the column using ImM-metoclopramide was retained and eluted from a wheatgerm lectin column (0.8 f 0.1 pg/ml compared with 42.0 f 3.2pg/ml added). The recovery of binding activity in the wheatgerm lectin eluates was variable, with activity being recovered on four out of seven occasions. When activity was recovered, about 12% of the receptor binding retained by the haloperidol affinity column could be measured in the eluates, giving a purification of 1327 f 280-fold (mean f s.E.M., n = 4). Representative results for the purification procedure are given in Table 1 .
The purification obtained by the present procedure is considerably below that required to produce a pure receptor preparation (about 100 000-fold needed if M , for receptor is 80 000). However, SDS/polyacrylamide-gel electrophoresis analysis of purified preparations (indicating a single major species of M , 80 000) suggests a considerably greater level of purification is being achieved than is apparent from the [' Hlspiperone-binding data ( S . Worrall, R. A. Williamson & P. G. Strange, unpublished work) . This disparity presum- Table I . PuriJication of D,-dopamine receptors ,from bovine brain Cholate-solubilized D,-receptors (Soluble preparation) were applied to a haloperidol-Sepharose affinity column. Unbound receptor was recovered in 'Run through' and 'Wash' fractions and bound receptor was eluted with metoclopramide ('Eluate'). Eluates were further purified on wheatgerm lectin(WGL)-Sepharose columns (Abbott & Strange, 1985) . Receptor binding and protein were assayed as described, except for (*) where binding was not determined because metoclopramide was present. 
